Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine in previously treated patients with severe haemophilia B. (Q42611760)
Jump to navigation
Jump to search
scientific article published on 3 August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine in previously treated patients with severe haemophilia B. |
scientific article published on 3 August 2011 |
Statements
1 reference
Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine in previously treated patients with severe haemophilia B. (English)
1 reference
A B Skotnicki
1 reference
M Serban
1 reference
M Colovic
1 reference
C Jinca
1 reference
A Klukowska
1 reference
P Laguna
1 reference
D M Wolf
1 reference
3 August 2011
1 reference
1 reference
18
1 reference
2
1 reference
175-181
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference